Key result
CD47 blockade may reduce arterial 18F-FDG uptake and suppress vascular inflammation.
Answers are grounded in this paper and cite their sources.
Shows that CD47 blockade reduces arterial 18F-FDG uptake and suppresses vascular inflammation, suggesting potential therapeutic value against vascular disease.
may reduce arterial 18 F-FDG uptake and suppress vascular inflammation. These preliminary observations require confirmation in a prospective trial.
No takes yet. Share an insight, caveat, or question.
Jarr et al. (2021) studied this question. CD47 blockade may reduce arterial 18F-FDG uptake and suppress vascular inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: